- Home
- ABUS vs AMTB Comparison
ABUS vs AMTB Comparison
Compare ABUS & AMTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABUS | AMTB |
|---|---|---|
| Founded | 2005 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 888.5M | 776.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ABUS | AMTB |
|---|---|---|
| Price | $4.84 | $20.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $5.00 | ★ $21.75 |
| AVG Volume (30 Days) | ★ 1.4M | 241.1K |
| Earning Date | 11-13-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.59 |
| Revenue | $14,606,000.00 | ★ $388,504,000.00 |
| Revenue This Year | $125.30 | $61.42 |
| Revenue Next Year | N/A | $2.10 |
| P/E Ratio | ★ N/A | $12.84 |
| Revenue Growth | ★ 116.64 | 51.98 |
| 52 Week Low | $2.71 | $15.62 |
| 52 Week High | $5.10 | $24.40 |
Technical Indicators
Market Signals| Indicator | ABUS | AMTB |
|---|---|---|
| Relative Strength Index (RSI) | 57.71 | 55.83 |
| Support Level | $4.65 | $19.27 |
| Resistance Level | $5.05 | $20.78 |
| Average True Range (ATR) | 0.22 | 0.46 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 67.46 | 55.38 |
Price Performance
Historical ComparisonAbout ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About AMTB Amerant Bancorp Inc.
Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.